The Enterprise Value as of December 2025 (TTM) for Maravai LifeSciences Holdings, Inc. (MRVI) is 1.74B

According to Maravai LifeSciences Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.74B. This represents a change of 95.09% compared to the average of 890.08M of the last 4 quarters.

Maravai LifeSciences Holdings, Inc. (MRVI) Historical Enterprise Value (quarterly & annually)

How has MRVI Enterprise Value performed in the past?

The mean historical Enterprise Value of Maravai LifeSciences Holdings, Inc. over the last ten years is 4.66B. The current 1.74B Enterprise Value has changed 3.63% with respect to the historical average. Over the past ten years (40 quarters), MRVI's Enterprise Value was at its highest in in the September 2021 quarter at 11.10B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Maravai LifeSciences Holdings, Inc. (MRVI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Maravai LifeSciences Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maravai LifeSciences Holdings, Inc. (MRVI) Average Enterprise Value

How has MRVI Enterprise Value performed in the past?

The current Enterprise Value of Maravai LifeSciences Holdings, Inc. (MRVI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Maravai LifeSciences Holdings, Inc. (MRVI) Enterprise Value vs. Peers

How is MRVI’s Enterprise Value compared to its peers?

Maravai LifeSciences Holdings, Inc.’s Enterprise Value is greater than Vir Biotechnology, Inc. (737.27M), greater than Prime Medicine, Inc. (728.20M), greater than Ginkgo Bioworks Holdings, Inc. (815.10M), greater than Replimune Group, Inc. (804.93M), greater than Iovance Biotherapeutics, Inc. (650.41M), greater than Kura Oncology, Inc. (961.31M), greater than Septerna, Inc. (875.41M), greater than Tyra Biosciences, Inc. (1.09B), greater than Bicara Therapeutics Inc. Common Stock (593.30M), greater than LENZ Therapeutics, Inc. (742.15M),

Build a custom stock screener for Maravai LifeSciences Holdings, Inc. (MRVI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Maravai LifeSciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Maravai LifeSciences Holdings, Inc. (MRVI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Maravai LifeSciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.